Skip to main content


Michael Matunis

Departmental Affiliations

School of Medicine

Michael Matunis, PhD, studies how protein modification by SUMO—the small ubiquitin-related modifier—drives changes in key cellular pathways from stress response to DNA repair.

Contact Info

615 N. Wolfe Street, Room W8118

Research Interests

Biochemistry and molecular biology; cell biology; SUMO; nuclear pore complexes; mitosis; malaria; ubiquitin; DNA repair
Experiences & Accomplishments
Northwestern University
Research in our laboratory centers on the functions of the SUMO family of small ubiquitin-related proteins. The covalent conjugation of SUMOs to other cellular proteins regulates a wide range of essential processes that include the replication and repair of DNA, the control of transcription initiation, trafficking of proteins and RNA between the nucleus and the cytoplasm and progression of cells through mitosis. Because all of these processes are essential for normal cell growth and differentiation, defects in SUMO conjugation are associated with a variety of human diseases, including cancer, neurodegenerative diseases and diabetes.
Studies in the lab are focused on characterizing the enzymes, and defining the molecular mechanisms, that regulate the conjugation of SUMO to specific proteins in the cell. We are also working to define and characterize the molecular effects that SUMO conjugation has on the properties and functions of modified proteins. Specific projects include: (1) Understanding how the conjugation of SUMO to mitotic chromosome-associated proteins is coordinated with progression through mitosis, and understanding how SUMO conjugation regulates the segregation of sister chromatids.  (2) Understanding how SUMO modification of BLM, the protein mutated in Bloom syndrome, affects its role in DNA repair and the maintenance of genome integrity.  (3) Understanding how sumoylation of proteins functions to protect cells from the effects of cytotoxic stress using S. cerevisiae as a model system.  
Lastly, projects in the lab are also focused on characterizing the SUMO pathway in malaria-causing parasite, P. falciparum, with the goal of developing parsite-specific inhibitors of SUMO conjugation that could be used treat malaria.
Honors & Awards
1984 PSU Department of Biochemistry Gilman Science Award 1988   Amoco Foundation Pre-doctoral Research Fellowship 1994 American Cancer Society Amgen Postdoctoral Fellowship 1998 JHSPH Faculty Innovation Award 1999 American Cancer Society Research Scholar Award 2003 March of Dimes Research Award 2003 JHMRI Pilot Award 2005 CFAR Pilot Award
Select Publications
Recent Publications
  • Odeh, H.M., E. Coyaud, B. Raught and M.J. Matunis. 2018. The SUMO-specific isopeptidase SENP2 is targeted to intracellular membranes via a predicted N-terminal amphipathic alpha-helix. Mol. Biol. Cell. mbcE17070445 (Epub ahead of print).
  • Lee, C.C., B. Li, H. Yu and M.J. Matunis. 2018. Sumoylation promotes optimal APC/C activation and timely anaphase. Elife. 7.pli:e29539.
  • Newman, H.A., P.B. Meluh, J. Lu, J. Vidal, C. Carson, E. Lagesse, J.J. Gray, J.D. Boeke and M.J. Matunis. 2017. A high throughput mutagenic analysis of yeast sumo structure and function. PLoS Genet. 13(2):e1006612.
  • McLaughlin, D., C.T. Coey, W.C. Yang, A.C. Drohat and M.J. Matunis. 2016. Characterizing requirements for SUMO modification and binding on base excision repair activity of thymine DNA glycosylase in vivo. J. Biol. Chem. 291:9014-9024.
  • Reither, K.H., A. Ramachandran, X. Xia, L.E. Boucher, J. Bosch and M.J. Matunis. 2016. Characterization and structural insights into selective E1-E2 interactions in the human and Plasmodium falciparum SUMO conjugation systems. J. Biol. Chem. 291:3860-3870.